These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6605358)

  • 1. Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders.
    Tomori N; Suda T; Tozawa F; Demura H; Shizume K; Mouri T
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1305-7. PubMed ID: 6605358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive corticotropin-releasing factor in human plasma.
    Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
    J Clin Invest; 1985 Nov; 76(5):2026-9. PubMed ID: 2997301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of corticotropin-releasing hormone: methodology and clinical application.
    Suda T; Tomori N; Sumitomo T; Nakagami Y; Tozawa F; Ushiyama T; Demura H; Shizume K
    Horm Metab Res Suppl; 1987; 16():47-51. PubMed ID: 3502116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-gamma-MSH levels in various disorders of pituitary-adrenal axis.
    Boscaro M; Giacomazzi P; Sonino N; Fallo F; Girard F; Bertagna X; Mantero F
    J Endocrinol Invest; 1990 Jan; 13(1):29-33. PubMed ID: 2156920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of circulating corticotrophin-releasing factor in man.
    Cunnah D; Jessop DS; Besser GM; Rees LH
    J Endocrinol; 1987 Apr; 113(1):123-31. PubMed ID: 3035045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor-binding protein concentrations in plasma of patients with hypothalamic-pituitary-adrenal disorders.
    Ohmori N; Suda T; Sato Y; Kasagi Y; Tozawa H; Dobashi I; Demura H
    Endocr J; 1994 Oct; 41(5):553-8. PubMed ID: 7889116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticotropin-releasing factor concentrations in cerebrospinal fluid and its diurnal rhythm in patients with Cushing's disease].
    Yokoe T; Kuwayama A; Ichihara K; Yamamoto N; Kageyama N
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):964-70. PubMed ID: 6334621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
    Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
    J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VALUE OF THE SERUM TUBIDITY TEST IN THE DIAGNOSIS OF PITUITARY AND ADRENAL HYPO- AND HYPERFUNCTION].
    KROL W; CIBA T
    Pol Tyg Lek; 1965 Feb; 20():169-71. PubMed ID: 14339819
    [No Abstract]   [Full Text] [Related]  

  • 19. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness of the hypophyseal-adrenocortical axis to corticotropin-releasing factor in pituitary-dependent Cushing's disease.
    Pieters GF; Hermus AR; Smals AG; Bartelink AK; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1983 Sep; 57(3):513-6. PubMed ID: 6308029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.